Back to top Open menu arrow
Purchase PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Insights April 6, 2021

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

; ; ;

J Clin Psychiatry 2020;81(3):OT19037BR3

Also from JCP

Thirty Years of the DCPR with Jenny Guidi, PsyD, PhD Worsening of Depression and Anxiety with Psilocybin The Role of Chronic Anhedonia in the Relationship Between Treatment-Resistant Depression and Suicidality

Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking antipsychotic medication.

Read the eReport

About the Authors

Buy PDF for $40

Please sign in or purchase this PDF for $40.

The Journal of Clinical Psychiatry September 2026 cover featuring key articles on depression therapy

Vol 87 • 2026 • Number 3

Read the Current Issue

Original Research

Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression

Original Research

US Mortality Involving Obesity and Psychiatric Disorders

Academic Highlights

Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report

Original Research

Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms

Original Research

Exposure-Based Video Therapy for OCD and PTSD

Original Research

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
View current Issue

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe